CAS NO: | 1240494-13-6 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | SX-517 is a dualCXCR2/1antagonist, containing boronic acid. SX-517 inhibits CXCL1-induced Ca2+flux (IC50=38 nM), and antagonizes CXCL8-induced [(35)S]GTPγS binding (IC50=60 nM) andERK1/2phosphorylation. SX-517 has significant ability for inflammation suppression, in both humanized polymorphonuclear (PMN) cells and in murine model[1][2]. | ||||||||
IC50& Target[1] |
| ||||||||
体外研究 (In Vitro) | SX-517 (compound 7) (0.1 nM-0.1 mM; 60 min) potently inhibits [35S]GTPγS binding induced by 10 nM CXCL8 with an IC50 of 60 nM[1]. Western Blot Analysis[1]
| ||||||||
体内研究 (In Vivo) | SX-517 (compound 7) (0.2 mg/kg; iv; single dose) significantly inhibits inflammation in an in vivo murine model[1].
| ||||||||
分子量 | 382.22 | ||||||||
Formula | C19H16BFN2O3S | ||||||||
CAS 号 | 1240494-13-6 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |